| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,731 |
11,307 |
$879K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,043 |
3,734 |
$265K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,606 |
4,284 |
$225K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,244 |
5,838 |
$173K |
| 99051 |
|
14,761 |
13,531 |
$171K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,383 |
5,755 |
$134K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,641 |
1,572 |
$78K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,241 |
4,689 |
$54K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,818 |
1,619 |
$17K |
| 99050 |
|
1,108 |
877 |
$10K |
| 87807 |
|
584 |
532 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
352 |
314 |
$452.52 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
108 |
93 |
$385.06 |
| 81003 |
|
248 |
228 |
$346.98 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
607 |
557 |
$199.24 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
43 |
38 |
$29.95 |
| A4208 |
Syringe with needle, sterile 3 cc, each |
1,880 |
1,651 |
$8.79 |